Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer.
Feliu J, Martín G, Castro J, Sundlov A, Rodriguez-Jaráiz A, Casado E, Lomas M, Madroñal C, Galán A, Belda C, Gonzalez-Barón M.
Feliu J, et al.
Cancer Chemother Pharmacol. 2006 Oct;58(4):527-31. doi: 10.1007/s00280-006-0198-5. Epub 2006 Mar 23.
Cancer Chemother Pharmacol. 2006.
PMID: 16555090
Clinical Trial.